News Your Patients Can Use: Medicare Announces Lower Prices on 10 Common, Expensive Drugs, Including PsO Medications
The list prices of Stelara (ustekinumab) and Enbrel (etanercept) for people on Medicare will be reduced by nearly 70% in 2026, the White House announced. This action is a result of the first round of Centers for Medicare & Medicaid Services (CMS) price negotiations with drugmakers. It comprises the 10 costliest prescription drugs under Medicare. […]